Qin He

928 total citations
21 papers, 734 citations indexed

About

Qin He is a scholar working on Molecular Biology, Biomaterials and Immunology. According to data from OpenAlex, Qin He has authored 21 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Biomaterials and 5 papers in Immunology. Recurrent topics in Qin He's work include RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (4 papers). Qin He is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (4 papers). Qin He collaborates with scholars based in China, South Korea and United States. Qin He's co-authors include Desheng Xiao, Pan Zou, Yongguang Tao, Hongyu Liu, Cheng Lei, Zhirong Zhang, Qianyu Zhang, Kairong Shi, Jianshu Li and Tao Gong and has published in prestigious journals such as Advanced Materials, Biomaterials and Journal of Controlled Release.

In The Last Decade

Qin He

21 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qin He China 14 425 219 168 110 73 21 734
Yanfang Ding China 16 428 1.0× 270 1.2× 115 0.7× 86 0.8× 85 1.2× 24 713
Cristian Moldovan Romania 17 322 0.8× 179 0.8× 91 0.5× 94 0.9× 51 0.7× 53 854
Longzhu Piao United States 18 473 1.1× 152 0.7× 194 1.2× 97 0.9× 56 0.8× 25 863
Zeting Yuan China 18 411 1.0× 194 0.9× 238 1.4× 275 2.5× 86 1.2× 31 1.0k
Vanminh Le China 14 226 0.5× 93 0.4× 112 0.7× 159 1.4× 37 0.5× 17 583
Aditya Ganju United States 14 595 1.4× 273 1.2× 256 1.5× 165 1.5× 40 0.5× 20 1.1k
Wei‐Hao Sun China 17 483 1.1× 179 0.8× 101 0.6× 41 0.4× 28 0.4× 41 1.1k
Ebrahim Rahmani Moghadam Iran 13 568 1.3× 319 1.5× 107 0.6× 94 0.9× 23 0.3× 18 946
Pradip Chaudhari India 15 311 0.7× 50 0.2× 166 1.0× 165 1.5× 87 1.2× 36 717

Countries citing papers authored by Qin He

Since Specialization
Citations

This map shows the geographic impact of Qin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin He more than expected).

Fields of papers citing papers by Qin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin He. The network helps show where Qin He may publish in the future.

Co-authorship network of co-authors of Qin He

This figure shows the co-authorship network connecting the top 25 collaborators of Qin He. A scholar is included among the top collaborators of Qin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin He. Qin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Qihang, Siqi Huang, Zihan Zhang, et al.. (2025). Integration of Photodiagnosis and Therapy Guided by Micro/Nanorobots. Advanced Materials. 37(18). e2420359–e2420359. 17 indexed citations
2.
Deng, Miao, Rong Guo, Yang Wang, et al.. (2023). Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy. Advanced Materials. 35(39). e2303736–e2303736. 25 indexed citations
3.
Wang, Xuhui, Dong Chen, Kexin Huang, et al.. (2023). Albumin‐Hitchhiking Drug Delivery to Tumor‐Draining Lymph Nodes Precisely Boosts Tumor‐Specific Immunity through Autophagy Modulation of Immune Cells. Advanced Materials. 35(29). 22 indexed citations
4.
Huang, Fengli, et al.. (2020). Meta-Analysis of CTLA-4 +49 Gene Polymorphism and Susceptibility to Graves' Disease. Critical Reviews in Eukaryotic Gene Expression. 30(5). 377–390. 4 indexed citations
5.
Wu, Xiaoli, X Chen, Hui Liu, et al.. (2020). Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis. Theranostics. 10(13). 5749–5762. 15 indexed citations
6.
Li, Man, Yuting Yang, Chaoqun Xu, et al.. (2019). Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy. The AAPS Journal. 21(2). 18–18. 10 indexed citations
7.
Tu, Can, Qin He, Chunyu Li, et al.. (2019). Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats. Frontiers in Pharmacology. 10. 335–335. 31 indexed citations
8.
Liu, Hongyu, Cheng Lei, Qin He, et al.. (2018). Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Molecular Cancer. 17(1). 64–64. 262 indexed citations
9.
Li, Chunyu, Qin He, Dan Gao, et al.. (2017). Idiosyncratic drug-induced liver injury linked to Polygonum multiflorum: A case study by pharmacognosy. Chinese Journal of Integrative Medicine. 23(8). 625–630. 16 indexed citations
10.
Yang, Yuting, Kairong Shi, Shaobo Ruan, et al.. (2016). A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR Effect. Theranostics. 6(12). 2141–2160. 35 indexed citations
11.
Shi, Kairong, Jin Zhou, Qianyu Zhang, et al.. (2014). Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme. Journal of Biomedical Nanotechnology. 11(3). 382–391. 47 indexed citations
12.
Yuan, Wenmin, Rui Kuai, Wei Cai, et al.. (2014). Increased Delivery of Doxorubicin Into Tumor Cells Using Extracellularly Activated TAT Functionalized Liposomes: <I>In</I> <I> Vitro</I> and <I>In</I> <I>Vivo</I> Study. Journal of Biomedical Nanotechnology. 10(8). 1563–1573. 13 indexed citations
13.
Fu, Han, Guanlian Hu, & Qin He. (2014). [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].. PubMed. 49(7). 1054–61. 3 indexed citations
14.
He, Qin, Wei Wu, Kemao Xiu, et al.. (2013). Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles. International Journal of Pharmaceutics. 443(1-2). 110–119. 55 indexed citations
15.
He, Qin, Jiaojiao Yang, Jiahui Li, Jianyu Xin, & Jianshu Li. (2013). Cyclodextrin-conjugated poly(lactic acid)- b –poly(ethylene glycol) micelles as a potential controlled drug release system. Journal of Controlled Release. 172(1). e60–e61. 2 indexed citations
16.
Lou, Jinning, et al.. (2013). The Anti-tumoral Efficacy of a Docetaxel-loaded Liposomal Drug Delivery System Modified with Transferrin for Ovarian Cancer. Drug Research. 64(4). 195–202. 14 indexed citations
17.
Zhang, Qianyu, Na He, Li Zhang, et al.. (2012). The <I>In Vitro</I> and <I>In Vivo</I> Study on Self-Nanoemulsifying Drug Delivery System (SNEDDS) Based on Insulin-Phospholipid Complex. Journal of Biomedical Nanotechnology. 8(1). 90–97. 45 indexed citations
18.
Zhang, Zhirong, Qiang Zheng, Jing Han, et al.. (2008). The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells. Biomaterials. 30(7). 1372–1381. 89 indexed citations
19.
Yuan, Wenmin, et al.. (2008). LHRHa aided liposomes targeting to human ovarian tumor cells: preparation and cellular uptake.. PubMed. 63(6). 434–8. 1 indexed citations
20.
He, Qin, et al.. (2002). Death Receptor 5 Regulation during Selenium-Mediated Apoptosis in Human. Cancer Biology & Therapy. 1(3). 287–290. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026